{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:12:12Z","timestamp":1791306732688,"version":"4.3.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"am","delay-in-days":675,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence nationale de la recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.bmcl.2021.127884","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T23:26:49Z","timestamp":1614122809000},"page":"127884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites"],"prefix":"10.1016","volume":"39","author":[{"given":"Manel","family":"Ouji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1277-7728","authenticated-orcid":false,"given":"Romain","family":"Musti\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Augereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9468-4823","authenticated-orcid":false,"given":"Fran\u00e7oise","family":"Benoit-Vical","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6435-5765","authenticated-orcid":false,"given":"C\u00e9line","family":"Deraeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2021.127884_b0005","unstructured":"World Health Organisation. World Malaria Report.; 2020. ISBN 978-92-4-001579-1."},{"key":"10.1016\/j.bmcl.2021.127884_b0010","unstructured":"World Health Organisation. Status Report on Artemisinin and ACT Resistance. World Health Organisation; 2015. https:\/\/apps.who.int\/iris\/handle\/10665\/338493."},{"key":"10.1016\/j.bmcl.2021.127884_b0015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3201\/eid1405.071601","article-title":"Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border","volume":"14","author":"Wongsrichanalai","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bmcl.2021.127884_b0020","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","article-title":"Evidence of Artemisinin-resistant malaria in Western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2021.127884_b0025","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1314981","article-title":"Spread of Artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2021.127884_b0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2021.127884_b0035","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1056\/NEJMoa1513137","article-title":"A worldwide map of Plasmodium falciparum K13-propeller polymorphisms","volume":"374","author":"M\u00e9nard","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2021.127884_b0040","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1473-3099(15)00487-9","article-title":"Dihydroartemisinin\u2013piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study","volume":"16","author":"Amaratunga","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmcl.2021.127884_b0045","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12916-015-0539-5","article-title":"Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations","volume":"13","author":"Duru","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.bmcl.2021.127884_b0050","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.01636-09","article-title":"Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism","volume":"54","author":"Witkowski","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2021.127884_b0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature12876","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2021.127884_b0060","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1086\/656476","article-title":"Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure","volume":"202","author":"Teuscher","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmcl.2021.127884_b0065","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1128\/AAC.02647-14","article-title":"Fatty acid synthesis and pyruvate metabolism pathways remain active in dihydroartemisinin-induced dormant ring stages of Plasmodium falciparum","volume":"58","author":"Chen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2021.127884_b0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12936-016-1206-9","article-title":"Plasmodium falciparum: multifaceted resistance to artemisinins","volume":"15","author":"Paloque","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.bmcl.2021.127884_b0075","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.4155\/fmc.13.121","article-title":"Targeting the mitochondrial electron transport chain of Plasmodium falciparum: New strategies towards the development of improved antimalarials for the elimination era","volume":"5","author":"Nixon","year":"2013","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmcl.2021.127884_b0080","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/infdis\/jiv048","article-title":"Mitochondrial membrane potential in a small subset of Artemisinin-induced dormant Plasmodium falciparum parasites in vitro","volume":"212","author":"Peatey","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmcl.2021.127884_b0085","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1093\/jac\/dkaa250","article-title":"Identification of compounds active against quiescent artemisinin-resistant Plasmodium falciparum parasites via the quiescent stage survival assay (QSA)","volume":"75","author":"Reyser","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmcl.2021.127884_b0090","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1416611112","article-title":"Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1","volume":"112","author":"Capper","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmcl.2021.127884_b0095","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3201\/eid2110.150682","article-title":"Induction of multidrug tolerance in Plasmodium falciparum by extended artemisinin pressure","volume":"21","author":"M\u00e9nard","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bmcl.2021.127884_b0100","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/jm058225d","article-title":"Designed multiple ligands. An emerging drug discovery paradigm","volume":"48","author":"Morphy","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127884_b0105","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1359-6446(04)03163-0","article-title":"From magic bullets to designed multiple ligands","volume":"9","author":"Morphy","year":"2004","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmcl.2021.127884_b0110","doi-asserted-by":"crossref","first-page":"e00249","DOI":"10.1128\/AAC.00249-17","article-title":"Are antimalarial hybrid molecules a close reality or a distant dream?","volume":"61","author":"Agarwal","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2021.127884_b0115","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/med.21643","article-title":"Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug-resistant Plasmodium falciparum","volume":"40","author":"Feng","year":"2020","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmcl.2021.127884_b0120","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/0006-2952(92)90213-3","article-title":"Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4\u2019-chlorophenyl) cyclohexyl]-3- hydroxy-1,4-naphthoquinone (566C80)","volume":"43","author":"Fry","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmcl.2021.127884_b0125","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1074\/jbc.M112000200","article-title":"Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase","volume":"277","author":"Perozzo","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2021.127884_b0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/84612","article-title":"Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum","volume":"7","author":"Surolia","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.bmcl.2021.127884_b0135","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1073\/pnas.0400891101","article-title":"Molecular basis for the inhibition of the carboxyltransferase domain of acetyl-coenzyme-A carboxylase by haloxyfop and diclofop","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2021.127884_b0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1073\/pnas.1416611112","article-title":"Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1","volume":"112","author":"Capper","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmcl.2021.127884_b0145","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10495-016-1265-y","article-title":"Mefloquine induces ROS mediated programmed cell death in malaria parasite: Plasmodium","volume":"21","author":"Gunjan","year":"2016","journal-title":"Apoptosis"},{"key":"10.1016\/j.bmcl.2021.127884_b0150","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1128\/AAC.21.4.581","article-title":"The antimalarial drug mefloquine binds to membrane phospholipids","volume":"21","author":"Chevli","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2021.127884_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2017.31","article-title":"Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis","volume":"2","author":"Wong","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bmcl.2021.127884_b0160","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","article-title":"Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: In-vitro and ex-vivo drug-response studies","volume":"13","author":"Witkowski","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmcl.2021.127884_b0165","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1016\/j.ejmech.2009.07.021","article-title":"Synthesis and antimalarial activity of new atovaquone derivatives","volume":"44","author":"El Hage","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127884_b0170","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1016\/j.bmc.2008.04.006","article-title":"Design, synthesis, and application of novel triclosan prodrugs as potential antimalarial and antibacterial agents","volume":"16","author":"Mishra","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2021.127884_b0175","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1128\/AAC.39.10.2217","article-title":"Antipneumocystis activity of 17C91, a prodrug of atovaquone","volume":"39","author":"Comley","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2021.127884_b0180","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/cmdc.200700166","article-title":"Atovaquone-Statine \u201cDouble-Drugs\u201d with high antiplasmodial activity","volume":"3","author":"Romeo","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2021.127884_b0185","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1021\/jm0705760","article-title":"Synthesis and structure\u2013activity relationships of 4-pyridones as potential antimalarials","volume":"51","author":"Yeates","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127884_b0190","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1021\/acs.jmedchem.7b01256","article-title":"Synthesis and structure\u2013activity relationships of the novel antimalarials 5-pyridinyl-4(1H)-pyridones","volume":"61","author":"Bueno","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.127884_b0195","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/cbic.200400347","article-title":"Design, synthesis and antimalarial activity of trifluoromethylartemisinin\u2013mefloquine dual molecules","volume":"6","author":"Grellepois","year":"2005","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmcl.2021.127884_b0200","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1016\/j.bmcl.2011.07.044","article-title":"Potent antimalarial 4-pyridones with improved physico-chemical properties","volume":"21","author":"Bueno","year":"2011","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21001104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21001104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:38:37Z","timestamp":1760773117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21001104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":40,"alternative-id":["S0960894X21001104"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.127884","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel molecule combinations and corresponding hybrids targeting artemisinin-resistant Plasmodium falciparum parasites","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.127884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"127884"}}